What is the recommended trimethoprim‑sulfamethoxazole (Bactrim) dose for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in adults and children, and how should the dose be adjusted for renal impairment or intolerance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bactrim Dose for PJP Prophylaxis

For adults, use one double-strength tablet (160/800 mg) daily or one double-strength tablet three times weekly on consecutive days; for children, use 150 mg/m² trimethoprim with 750 mg/m² sulfamethoxazole daily, divided into two doses and given three times weekly on consecutive days. 1

Adult Dosing

The FDA-approved prophylactic regimen is one double-strength tablet (TMP 160 mg/SMX 800 mg) daily 1. However, the three-times-weekly dosing on consecutive days is equally endorsed and widely used in clinical practice 2, 3.

Standard Regimens (in order of preference):

  • 1 DS tablet daily - Most commonly prescribed
  • 1 DS tablet three times weekly on consecutive days (e.g., Monday-Tuesday-Wednesday)
  • 1 single-strength tablet (80/400 mg) daily - Alternative for tolerability

Recent evidence strongly supports that lower-dose regimens maintain efficacy while significantly reducing adverse events. Studies show no breakthrough PJP infections with doses as low as one single-strength tablet every other day, three times weekly 4, and twice-weekly dosing on non-consecutive days 5, 6.

Pediatric Dosing

For children ≥2 months: 150 mg/m² TMP with 750 mg/m² SMX per day, divided into two doses, given three times weekly on consecutive days (maximum 320 mg TMP/1600 mg SMX daily) 2, 1.

Practical pediatric dosing by body surface area:

  • 0.26-0.53 m²: ½ tablet twice daily on prophylaxis days
  • 0.53-1.06 m²: 1 tablet twice daily on prophylaxis days

Critical contraindication: Bactrim is absolutely contraindicated in infants <2 months of age 1.

Renal Dose Adjustment

For creatinine clearance 15-30 mL/min: reduce dose to 50% of standard regimen 1.

For creatinine clearance <15 mL/min: use is not recommended 1.

However, emerging evidence in hemodialysis patients suggests that very low doses (<6 single-strength tablets per week) maintain prophylactic efficacy with significantly fewer adverse events compared to standard dosing 7. For patients with even mild renal impairment (CrCl ≤64 mL/min or SCr ≥0.78 mg/dL), consider starting with reduced dosing as they have significantly higher discontinuation rates with standard doses 8.

Managing Intolerance

If patients cannot tolerate standard dosing due to adverse effects:

Step-down approach:

  1. First: Reduce to 1 single-strength tablet daily
  2. Second: Reduce to 1 single-strength tablet every other day, three times weekly
  3. Third: Reduce to 1 single-strength tablet twice weekly on non-consecutive days

Research demonstrates that even twice-weekly dosing on non-consecutive days prevents breakthrough PJP 5, 6, with one study showing 0% PJP incidence and significantly lower discontinuation rates (12.1% vs 35.6% yearly) compared to standard dosing 7.

Alternative agents if TMP-SMX must be discontinued:

  • Dapsone: 100 mg daily (or 2 mg/kg in children)
  • Atovaquone: 1500 mg daily (30-45 mg/kg in children depending on age)
  • Aerosolized pentamidine: 300 mg monthly (children ≥5 years only) 2

Key Clinical Pearls

Daily TMP-SMX provides additional benefits beyond PJP prophylaxis, including reduction in bacterial respiratory infections and toxoplasmosis protection 3. This should be considered when selecting among dosing regimens.

Common pitfall: Prescribers often maintain high doses unnecessarily. The evidence strongly supports that lower doses (even twice weekly) maintain efficacy while dramatically reducing adverse events including hyperkalemia, neutropenia, thrombocytopenia, and hepatotoxicity 9, 8, 6.

For transplant recipients: Low-dose regimens (80/400 mg daily or 160/800 mg every other day) show equivalent efficacy to full-dose prophylaxis (0% vs 1% vs 11% PJP incidence for full-dose, low-dose, and no prophylaxis respectively) 10.

Monitoring: Watch for hyperkalemia (2.6% incidence), neutropenia (13.3%), thrombocytopenia (8.1%), elevated creatinine (15.9%), and transaminitis (5.9%) even with low-dose regimens 9.

References

Research

Low-Dose TMP-SMX for Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Solid Organ Transplant Recipients.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2023

Related Questions

What is the recommended treatment for a patient diagnosed with PJP (Pneumocystis jirovecii pneumonia), considering potential sulfa allergy or intolerance and severity of the condition?
In an immunocompromised patient receiving trimethoprim‑sulfamethoxazole (Bactrim) for Pneumocystis jirovecii pneumonia prophylaxis, should Bactrim be continued when the patient is admitted for sepsis and started on vancomycin and piperacillin‑tazobactam (Zosyn)?
What are the recommended prophylactic doses of trimethoprim‑sulfamethoxazole for Pneumocystis jirovecii pneumonia, including adjustments for renal impairment?
How long should Pneumocystis jirovecii pneumonia (PJP) prophylaxis be continued in individuals taking high-dose steroids?
What is the appropriate dose of trimethoprim‑sulfamethoxazole (TMP‑SMX) for PCP (Pneumocystis jirovecii pneumonia) prophylaxis in a glioblastoma patient receiving concurrent temozolomide chemotherapy, radiotherapy, and steroids?
What withdrawal symptoms can occur when an adult discontinues lisdexamfetamine (Elvanse) 50 mg, and how should the taper be managed?
When should serum luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) be measured in men, and how do the results help differentiate primary versus secondary hypogonadism and guide further evaluation?
What is the ICD‑10 code for a bone density screening (DXA) for osteoporosis?
What concentration of Dakin's solution should be used for wound irrigation?
What ICD‑10‑CM code should be used for a colonoscopy performed as a routine screening in an asymptomatic patient?
Can Fusobacterium necrophorum cause tonsillitis in a patient with normal-sized tonsils?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.